NorthWest Biotherapeutics Inc (NWBO)

[skitahoe]

With us approaching day 120, and then only 30 more to 150 I've got to believe that patients following the approval deadline would await the deadline with their tumors properly preserved. If approved, they're ready to go, if delayed they can continue going for compassionate use.

As I see it, people who've very recently had surgery, or are about to, do have some time to get the vaccine. For the patients who're 3 to 6 months from surgery, they've probably applied for compassionate use if they've managed to raise the funds. I'm not suggesting that time is of no concern, but if you add the Poly-ICLC and/or Keytruda I suspect that getting the vaccine in 9 months or so after surgery gives the patient a very good chance of getting the benefit.

I think the bigger question may be patients who's tumor has been properly store, who're surviving, but where it's now a year or more from surgery, how does one establish the priority for making the vaccine.

Gary